Valuation AFT Pharmaceuticals Limited

Stocks

End-of-day quote New Zealand S.E. 23/10/2026			5-day change	1st Jan Change
4.640 ^NZD	+1.09%		+4.27%	+37.28%

10-06	ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance	MT
10-05	AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	378	362.8	328.2	282.1	352.4	486.6	-	-
Change	-	-4%	-9.54%	-14.06%	24.91%	38.11%	-	-
Enterprise Value (EV) ¹	407.3	392.7	344.4	296.6	391	516.5	511.2	506.8
Change	-	-3.57%	-12.3%	-13.89%	31.82%	32.1%	-1.01%	-0.87%
P/E	19x	34.6x	20.9x	24.5x	24x	24.7x	19.6x	18.3x
PBR	6.66x	4.95x	3.74x	2.89x	3.2x	5.32x	4.44x	3.66x
PEG	-	-0.7x	0.4x	-0.9x	0.9x	0.7x	0.8x	2.59x
Capitalization / Revenue	2.9x	2.32x	1.68x	1.36x	1.38x	1.6x	1.41x	1.24x
EV / Revenue	3.13x	2.51x	1.76x	1.43x	1.53x	1.7x	1.48x	1.29x
EV / EBITDA	19x	18.4x	13.1x	14.2x	13.6x	14.9x	12.3x	10.2x
EV / EBIT	20x	20x	14.2x	16.8x	16x	16.9x	13.8x	11.2x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	0.016	0.018	0.025	0.0328	0.0416	0.0652
Rate of return	-	-	0.51%	0.67%	0.74%	0.71%	0.9%	1.4%
EPS ²	0.19	0.1	0.15	0.11	0.14	0.1878	0.2366	0.2533
Distribution rate	-	-	10.7%	16.4%	17.9%	17.4%	17.6%	25.7%
Net sales ¹	130.3	156.6	195.4	208	254.7	303.8	345.2	392.5
EBITDA ¹	21.43	21.39	26.25	20.88	28.8	34.63	41.41	49.9
EBIT ¹	20.39	19.67	24.24	17.65	24.44	30.64	37.05	45.17
Net income ¹	19.85	10.65	15.61	11.96	14.73	19.7	24.81	26.56
Net Debt ¹	29.3	29.9	16.2	14.5	38.6	29.84	24.6	20.14
Reference price ²	3.610	3.460	3.130	2.690	3.360	4.640	4.640	4.640
Nbr of stocks (in thousands)	104,697	104,866	104,866	104,866	104,866	104,875	-	-
Announcement Date	22/05/22	22/05/23	22/05/24	21/05/25	20/05/26	-	-	-

¹NZD in Million²NZD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
AFT PHARMACEUTICALS LIMITED	24.7x	1.7x	14.92x	0.71%	277M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.02x	6.50x	18.32x	1.98%	400.39B
Weighted average by Cap.	35.23x	8.29x	20.39x	1.8%